Medicine and Dentistry
Overall Survival
100%
Diffuse Large B-Cell Lymphoma
87%
Malignant Neoplasm
77%
Oncology
60%
B Cell
51%
Rituximab
42%
Neoplasm
40%
Chemoradiotherapy
34%
Pancreas Cancer
32%
Cancer
30%
Metastatic Carcinoma
30%
Surgery
27%
Disease
27%
Pancreas Adenocarcinoma
26%
Event Free Survival
24%
Germinal Center
23%
Hepatectomy
23%
Adolescent
22%
Non Small Cell Lung Cancer
22%
Vitamin D
21%
Stereotactic Body Radiation Therapy
21%
Gene Expression Profiling
21%
Prognostic Factor
20%
Cancer Cell
20%
Follicular Lymphoma
20%
In Vitro
19%
Clinical Trial
19%
Diagnosis
19%
Non-Hodgkin Lymphoma
18%
Multivariate Analysis
18%
Adjuvant Chemotherapy
18%
Supplementation
18%
Surgical Oncology
17%
Cardiopulmonary Bypass
16%
Epidermal Growth Factor Receptor
16%
B-Cell Lymphoma
16%
Lymphoblastic Lymphoma
16%
Mucin 4
16%
Meta-Analysis
16%
Cytoreductive Surgery
16%
Peripheral T-Cell Lymphoma
16%
Squamous Cell Carcinoma
15%
Neoadjuvant Therapy
14%
Immunohistochemistry
13%
Platelet
13%
Vincristine
13%
Doxorubicin
13%
Breast Cancer
12%
Pediatrics
12%
Glioblastoma
12%
Keyphrases
Diffuse Large B-cell Lymphoma (DLBCL)
41%
Overall Survival
35%
Rituximab
24%
Children's Oncology Group
21%
MUC4
21%
Early-stage Lung Cancer
21%
Vitamin D Supplementation
21%
Follicular Lymphoma
20%
Malignancy
18%
Serum 25OHD
18%
Pancreatic Ductal Adenocarcinoma
18%
Vitamin D
17%
Metastasis
16%
Hepatic Resection
16%
Preoperative Nomogram
16%
Global Curriculum
16%
Adjuvant Chemotherapy
16%
Meta-analysis
16%
Germinal Center B Cells
15%
Pancreatic Cancer
15%
Confidence Interval
14%
Resectable Pancreatic Cancer
12%
Cancer-related
12%
Immunohistochemistry
12%
Locally Advanced
12%
Nebraska
12%
Chemotherapy
12%
Global Variation
11%
Postoperative Mortality
11%
Cancer Mortality
11%
Colorectal Metastases
10%
Cell of Origin
10%
Calcium Absorption
10%
Genomic Analysis
10%
Peripheral T-cell Lymphoma
10%
Chemoradiotherapy
10%
Older Women
10%
Mantle Cell Lymphoma
10%
Stereotactic Body Radiation Therapy
10%
Negative Margins
10%
Group Reports
10%
Diffuse Component
10%
Gallbladder Cancer
10%
Tumor
10%
Median Overall Survival
10%
Anthracycline-based Chemotherapy
10%
Multivariate Analysis
9%
Vitamin D3
9%
Nomogram
9%
Cancer Patients
9%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
47%
T Cell
35%
Mouse
34%
B Cell
31%
Mucin
30%
Vitamin D
28%
Gene Expression Profiling
27%
Gene Expression
25%
Overall Survival
24%
MUC4
19%
MicroRNA
16%
Synthase
16%
MUC5AC
16%
Catenin
14%
Cytokine
14%
Microarrays
13%
Carcinogenesis
13%
CA19-9
13%
Mouse Model
12%
DNA Methyltransferase
12%
PAX7
12%
Cadherin
12%
Mortality Rate
11%
Clinical Trial
11%
CD8
11%
Cell Migration
11%
Epidermal Growth Factor Receptor
10%
Pyrophosphate
10%
Differential Gene Expression
10%
Randomized Controlled Trial
10%
Fibroblast
10%
Cytogenetics
10%
P53
10%
Tumor Progression
10%
FOXO1
9%
Radiosensitivity
9%
Autoantibodies
9%
Genetics
9%
DNA Damage Response
9%
Driving Ability
9%
PAX3
8%
Gene Signature
8%
Signal Transduction
8%
Natural Killer Cell
8%
Macrophage
8%
Karyotype
8%
Amplicon
8%
Cyclin D1
8%
Upregulation
7%
Precursor
7%